Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

NCT06999603 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Pneumonia

Interventions

DRUG: SNG001
DRUG: Placebo

Sponsor

Synairgen Research Ltd.